Drugplain

Griseofulvin 125 mg/5mL

Griseofulvin (microsize) · SUSPENSION · Chartwell RX, LLC.

No Recall History
Plain English

Griseofulvin is a suspension containing griseofulvin (microsize) at 125 mg/5mL, taken oral. Manufactured by Chartwell RX, LLC..

Key Facts

Brand Name
Griseofulvin
Generic Name
Griseofulvin (microsize)
NDC Code (Product)
62135-968
Manufacturer
Chartwell RX, LLC.
Strength
125 mg/5mL
Dosage Form
SUSPENSION
Route
ORAL
Marketing Status
Application #
ANDA065200
Drug Class
Tubulin Inhibiting Agent [EPC]
Marketing Start
03/02/2005

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective39 reports
headache15 reports
off label use13 reports
rash12 reports
pyrexia11 reports
diarrhoea10 reports
drug hypersensitivity10 reports
pathogen resistance10 reports
drug reaction with eosinophilia and systemic symptoms9 reports
drug resistance9 reports

Frequently Asked Questions

What is Griseofulvin used for?

Griseofulvin contains Griseofulvin (microsize). It is a suspension taken oral. Consult your doctor for specific uses.

Is Griseofulvin a controlled substance?

Griseofulvin is not classified as a controlled substance by the DEA.

What is the generic name for Griseofulvin?

The generic name for Griseofulvin is Griseofulvin (microsize). There are no other listed brand versions of Griseofulvin (microsize).

What is the NDC code for Griseofulvin 125 mg/5mL?

The NDC (National Drug Code) for Griseofulvin 125 mg/5mL is 62135-968, listed by Chartwell RX, LLC..

Product NDC

62135-968

Package NDC

62135-968-41

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)